|
|||||
       |
(Veterans Health Administration) 15 April 2014. Engineers in the U.K. at University of Southampton and Chas A Blatchford & Son Ltd. in Basingstoke are designing a liner with sensors for lower-limb prosthetic devices that improve the fit and comfort of those devices for their wearers. The team is developing a prototype device that . . . → Read More: Intelligent Liner Aims to Improve Prosthetic Limb Comfort  Comments are closed  Joint ventures/collaborations, New products  biomedical, disabled, engineering, Europe, medical device, physical sciences, U.K., university Patrick Doyle (Mass. Institute of Technology) 14 April 2014. Engineers at Massachusetts Institute of Technology and the affiliated Lincoln Laboratory developed a process for adding minute particles into materials that can be encoded and sensed by inexpensive readers to detect counterfeit goods from the originals. The team from the lab of chemical engineering . . . → Read More: Microparticle Solution Devised to Identify Genuine Goods Comments are closed New products, Regulations chemistry, engineering, manufacturing, materials science, nanotechnology, patent, physical sciences, university, water (TSA.gov) 9 April 2014. Science & Enterprise is taking a brief hiatus, while I travel for the remainder of this week, 10-12 April. The blog will return on Monday, 14 April. * * * MRSA bacteria emerge from dead white blood cells (Frank DeLeo, NIH) 9 April 2014. Researchers in the U.K., U.S., Sweden, and Turkey developed a technique based on genomic sequencing to predict the pathogenic severity of methicillin resistant Staphylococcus aureus or MRSA bacteria, an antibiotic-resistant microbe often found in health care facilities. The team . . . → Read More: MRSA Toxicity Predicted Through Genomic Sequencing Comments are closed New products biomedical, Europe, genomics, life sciences, medical device, U.K., university (Univ of California, San Francisco) 9 April 2014. University of California in San Francisco opened an online registry that aims to reduce the time and cost of recruiting participants in clinical trials for disorders of the brain, such as Alzheimer’s and Parkinson’s disease and traumatic brain injuries. The Brain Health Registry is led . . . → Read More: UC-San Francisco Launches Brain Disease Trial Registry Comments are closed Joint ventures/collaborations, New products biomedical, clinical trials, life sciences, software, university Microfluidic chip (Sandia National Lab) 8 April 2014. Computer scientists in the U.K. at Southampton University and circuit board manufacturer Newbury Electronics Ltd. are designing a device to detect protein indicators for diagnosing diseases at a doctor’s office or clinic rather than sending out samples to a lab for analysis. The three-year project . . . → Read More: University, Board Maker Partner on Point-of-Care Diagnostics Comments are closed Finance, Joint ventures/collaborations biomedical, computer science, engineering, Europe, grant, life sciences, medical device, nanotechnology, physical sciences, semiconductors, U.K., university XCaps dry-powder inhaler (Hovione International) 7 April 2014. Medical device manufacturer Hovione International in Lisbon, Portugal, received a patent for its inhaler for administering respiratory drugs in dry powder form. U.S. Patent and Trademark Office awarded patent 8,677,992 on 25 March to three inventors and assigned to Hovione International. Among the inventors is Peter . . . → Read More: U.S. Patent Granted for Simple Dry-Powder Drug Inhaler Comments are closed Intellectual property biomedical, engineering, Europe, medical device, patent, physical sciences, USPTO (National Cancer Institute) 7 April 2014. EMD Serono, a subsidiary of the pharmaceutical company Merck in Rockland, Massachusetts, is beginning a clinical trial to test a vaccine-type therapy for advanced cases of non-small cell lung cancer. The late-stage trial is assessing the ability of tecemotide, an experimental drug designed to trigger an immune . . . → Read More: Clinical Trial to Test Advanced Lung Cancer Immunotherapy Comments are closed Regulations Asia, biomedical, biotechnology, cancer, clinical trials, Europe, life sciences, pharmaceuticals PET scanner (U.S. Department of Energy) 4 April 2014. RefleXion Medical, a company in Burlingame, California designing a more accurate form of radiation therapy to treat solid tumors, gained $11.6 million in its first round of venture financing. The financing was lead by venture capital company Sofinnova Partners, with participation by Pfizer Venture . . . → Read More: Cancer Radiotherapy Company Lands $11.6M First Round Funds Comments are closed Finance biomedical, cancer, computer science, engineering, entrepreneurs, equity, investment, life sciences, mathematics, medical device, physical sciences, university, venture capital 3-D brain wiring illustration (NIH) 4 April 2014. The pharmaceutical company Daiichi Sankyo in Tokyo and University of California in San Francisco (UCSF) are collaborating on discovering new drugs to treat neurodegenerative conditions such as Alzheimer’s, Parkinson’s, and Creutzfeldt-Jakob disease. While funding amounts were not disclosed, the deal gives Daiichi Sankyo the option . . . → Read More: Daiichi Sankyo, UCSF Partner on Neurodegenerative Disorders Comments are closed Joint ventures/collaborations Asia, biomedical, Japan, licensing, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.